New safety program to monitor Medicare drug use
AP/Yahoo News, May 23, 2008
Federal health officials will begin monitoring prescription drug usage by Medicare participants in an effort to identify potential safety problems. New regulations will enable the FDA, states and academic researchers to screen the Medicare claims data. The FDA primarily relies on physicians and patients to report suspected adverse events, and it often takes a number of cases before someone at the agency detects a pattern that's worth investigating. But now at the first hint of trouble, the FDA now will be able to query databases involving tens of millions of patients.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Carondelet to Pay $35M to Settle Fraud Allegations
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- CA Powers Up $80M HIE to 'Create Value in the Data'
- 3 Traits Personality Assessments Can't Reveal